ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns

Zeng, Fanhong; Zhang, Yue; Han, Xu; Zeng, Min; Gao, Yi*; Weng, Jun*南方医科大学; y
Frontiers in Immunology2021-1-26DOI: 10.3389/fimmu.2020.609900
17被引19阅读
引用收藏
分享

摘要

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide with rising rates in parallel to obesity, type 2 diabetes, and metabolic syndrome. NAFLD includes pathologies ranging from simple steatosis (NAFL) to non-alcoholic steatohepatitis and cirrhosis (NASH), which may eventually develop into hepatocellular carcinoma (HCC). Mechanically, lipids accumulation and insulin resistance act as the first hit, inflammation and fibrosis serve as the second hit. Currently, the diagnosis of NAFLD mainly depends on pathology examination and medical imaging, whereas proper gene signature classifiers are necessary for the evaluation of disease status. Here, we developed three signature classifiers to distinguish different NAFLD disease states (NAFL and NASH). Moreover, we found that B cells, DCs, and MAIT cells are key deregulated immune cells in NAFLD, which are associated with NAFLD and NAFLD-HCC progression. Meanwhile, AKR1B10 and SPP1 are closely related to the above three immune cell infiltrations and immunosuppressive cytokines expressions in NAFLD and NAFLD-HCC. Subsequently, we screened out AKR1B10 and SPP1 sensitive molecules TGX-221, which may provide a possible therapy for NAFLD and NAFLD-HCC.

学科与关键词

关键词
non-alcoholic fatty liver diseaseinflammationsignature classifiersimmune microenvironmentdrug sensitivity
相关
加载中…
  • Comprehensive Analysis of NAFLD and the Therapeutic Target Identified
    Wen, Weiheng; Wu, Peili; Zhang, Yugang; Chen, Zijian; Sun, Jia*; Chen, Hong*Frontiers in Cell and Developmental Biology, 2021, 09: 704704.被引 13
  • Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease
    Yu, Xiaoxiao; Guo, Zihao; Fang, Zhihao; Yang, Kai; Liu, Changxu; Dong, Zhichao; Liu, ChangFrontiers in Genetics, 2023, 14: 1251999.
  • Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
    Wang, Siyuan; Li, Yiling; Liu, Ning; Shen, Wei; Xu, Wenhao; Yao, Peng*Genetical Research, 2022, 2022: 8566342.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2021-01-26
卷期
第 11 卷
页码
609900
DOI
10.3389/fimmu.2020.609900
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Key R&D Program of China [2018YFC1106400, 2018YFA0108200]; Science and Technology Planning Project of Guangdong Province [2015B020229002]; National Natural Science Foundation of China [31972926]; Natural Science Foundation of Guangdong Province [2014A030312013,2018A030313128]; Guangdong key research and development plan [2019 B020234003]; Science and Technology Program of Guangzhou [201803010086]

作者

  • Z

    Zeng, Fanhong (第一作者)

    southern med univ

  • Z

    Zhang, Yue

    southern med univ

查看全部 6 位作者收起作者
  • H

    Han, Xu

    southern med univ

  • Z

    Zeng, Min

    southern med univ

  • G

    Gao, Yi (通讯)

    southern med univ

  • W

    Weng, Jun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417